Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
If You Could Only Hold 3 Investments for Life, Consider These
Warren Buffett, who is known to own “forever stocks,” has famously quipped that if you aren't willing to own a stock for 10 years, you shouldn't own it for even 10 minutes.
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice
Does Inari Medical, Inc. (NARI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Inari Medical Inc. Profile
| - Industry | - Sector | Mr. Andrew J. Hykes CEO | NASDAQ (NGS) Exchange | US45332Y1091 ISIN |
| US Country | 1,300 Employees | - Last Dividend | - Last Split | 22 May 2020 IPO Date |
Overview
Inari Medical, Inc. is a pioneer in the development of minimally invasive, catheter-based mechanical thrombectomy devices and accessories, aiming to revolutionize treatment in specific disease states across the United States. Initially known as Inceptus Newco1 Inc., the company rebranded to Inari Medical, Inc. in September 2013, marking a new chapter in its quest to tackle complex vascular conditions with innovative solutions. Since its foundation in 2011, and operating out of its headquarters in Irvine, California, Inari Medical has dedicated itself to serving the needs of interventional radiologists, cardiologists, and vascular surgeons through its groundbreaking products.
Products and Services
- ClotTriever System
Designed for the effective treatment of deep vein thrombosis and peripheral thrombus, the ClotTriever system stands out for its ability to core, capture, and remove large clots from large vessels. This minimally invasive solution offers a new avenue for treating conditions that would have previously required more invasive surgical interventions.
- FlowTriever System
This innovative mechanical thrombectomy system revolutionizes the treatment of pulmonary embolism and other complex venous thromboembolism cases through large bore catheter-based aspiration. The FlowTriever system is specifically engineered to remove large clots from the peripheral vasculature, offering a safer and more efficient treatment option.
- InThrill System
Focusing on the treatment of small vessel thrombosis, the InThrill system introduces a novel approach by combining the latest advancements in catheter-based technologies. It is designed to address the challenges associated with accessing and effectively treating thrombosis in smaller vessels.
- LimFlow System
Targeting patients who suffer from chronic limb-threatening ischemia and have no suitable endovascular or surgical revascularization options, the LimFlow system presents a groundbreaking alternative. This technology potentially reduces the risk of major amputations by providing a new method for revascularizing affected limbs, transforming the treatment landscape for this debilitating condition.
Contact Information
